chr6-151544600-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_025059.4(CCDC170):āc.472A>Gā(p.Lys158Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025059.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC170 | NM_025059.4 | c.472A>G | p.Lys158Glu | missense_variant | 4/11 | ENST00000239374.8 | |
CCDC170 | XM_011536147.3 | c.490A>G | p.Lys164Glu | missense_variant | 4/11 | ||
CCDC170 | XM_011536148.3 | c.490A>G | p.Lys164Glu | missense_variant | 4/10 | ||
CCDC170 | XM_047419372.1 | c.472A>G | p.Lys158Glu | missense_variant | 4/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC170 | ENST00000239374.8 | c.472A>G | p.Lys158Glu | missense_variant | 4/11 | 1 | NM_025059.4 | P1 | |
CCDC170 | ENST00000544131.1 | n.462A>G | non_coding_transcript_exon_variant | 3/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152260Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 249088Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135132
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460952Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 726630
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.472A>G (p.K158E) alteration is located in exon 4 (coding exon 4) of the CCDC170 gene. This alteration results from a A to G substitution at nucleotide position 472, causing the lysine (K) at amino acid position 158 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at